Brief: Celltrion Receives Approval From U.S. FDA To Bring Yuflyma To Market
24/05/2023 03:18
May 24 (Reuters) - Celltrion Inc 068270.KS :
* CELLTRION: RECEIVES APPROVAL FROM U.S. FDA TO BRING
YUFLYMA TO
MARKET
Further company coverage: 068270.KS
Recent news on Celltrion
See all newsBrief: Celltrion Inc To Acquire 100 Billion Won Worth Of Own Shares
Brief: Celltrion Q1 Operating. Profit 322 Billion Won, Up 115% Y/Y
Brief: Celltrion To Cancel 100 Billion Won Treasury Shares
Brief: Celltrion Plans Phase 3 Clinical Trials For Keytruda Biosimilar With 220 Patients
Brief: Celltrion To Buy 100 Billion Won Of Own Shares